Please enable JavaScript to continue using this application.

Compare $IOVA vs $KOD | Chartloom

Compare

$IOVA vs $KOD

Iovance Biotherapeutics Inc · Kodiak Sciences Inc

IOVA

Iovance Biotherapeutics Inc

KOD

Kodiak Sciences Inc

Compare $IOVA vs $KOD

Comparing Iovance Biotherapeutics Inc and Kodiak Sciences Inc

IOVAIovance Biotherapeutics Inc

KODKodiak Sciences Inc

IOVAIovance Biotherapeutics Inc

Market cap

$6.53B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

12.69x

Rev growth (TTM)

34.5%

YTD performance

480.2%

52W performance

544.1%

FCF yield

-4.5%

KODKodiak Sciences Inc

Market cap

$6.25B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

283.8%

52W performance

590.7%

FCF yield

-2.6%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

IOVA

KOD

Detailed metrics comparison

IOVA

Iovance Biotherapeutics Inc

KOD

Kodiak Sciences Inc

Market Cap

IOVA$6.53B

KOD$6.25B

Enterprise Value

IOVA$6.42B

KOD$6.12B

Price

IOVA$14.62

KOD$99.87

P/E Ratio

IOVAN/A

KODN/A

P/S Ratio

IOVA20.09x

KOD0.00x

EV/Sales

IOVA19.75x

KOD0.00x

EV/EBITDA

IOVA0.00x

KOD0.00x

P/B Ratio

IOVA8.75x

KOD97.16x

P/FCF Ratio

IOVAN/A

KODN/A

EV/FCF

IOVA-21.65x

KOD-38.30x

PEG Ratio

IOVAN/A

KODN/A

Forward P/E (NTM)

IOVAN/A

KODN/A

Forward P/S (NTM)

IOVA12.69x

KODN/A

Revenue (TTM)

IOVA$325M

KOD$0

Revenue Growth (YoY)

IOVA34.5%

KODN/A

Forward Rev Growth

IOVA39.2%

KOD455.7%

Gross Margin (TTM)

IOVA48.4%

KOD0.0%

Operating Margin (TTM)

IOVA0.0%

KOD0.0%

EBITDA Margin (TTM)

IOVA-79.8%

KOD0.0%

Net Margin (TTM)

IOVA-89.1%

KOD0.0%

FCF Margin (TTM)

IOVA-91.2%

KODN/A

Net Income (TTM)

IOVA$-290M

KOD$-242M

FCF (TTM)

IOVA$-296M

KOD$-160M

EPS (TTM)

IOVA-$0.64

KOD-$3.86

ROE (TTM)

IOVA-4051.0%

KOD-27323.0%

ROA (TTM)

IOVA-3165.0%

KOD-8548.0%

ROIC (TTM)

IOVA-4047.0%

KOD-27323.0%

Cash

IOVA$111M

KOD$126M

Debt

IOVA$0

KOD$0

Net Cash/Debt

IOVA$111M

KOD$126M

Current Ratio (TTM)

IOVA4.35x

KOD2.49x

Quick Ratio (TTM)

IOVA3.74x

KOD2.39x

Debt/Equity (TTM)

IOVA0.00x

KOD0.00x

Debt/Assets (TTM)

IOVA0.0%

KOD0.0%

Interest Coverage (TTM)

IOVAN/A

KODN/A

Net Debt/EBITDA (TTM)

IOVA0.00x

KOD0.00x

Beta

IOVA0.76

KOD1.95

52W Performance

IOVA544.1%

KOD590.7%

YTD Performance

IOVA480.2%

KOD283.8%

% from 52W High

IOVA-4.4%

KOD-4.0%

% from 52W Low

IOVA730.7%

KOD812.9%

Asset Turnover (TTM)

IOVA0.36x

KOD0.00x

FCF Yield (TTM)

IOVA-4.5%

KOD-2.6%

Earnings Yield (TTM)

IOVA-4.4%

KOD-3.9%

Dividend Yield (TTM)

IOVAN/A

KODN/A

Rule of 40

IOVA-56.7

KOD0.0

EV/GP/RG

IOVA0.68

KODN/A

Ticker research

View IOVA research View KOD research

Metric	IOVA Iovance Biotherapeutics Inc	KOD Kodiak Sciences Inc
Market & Valuation
Market Cap	$6.53B	$6.25B
Enterprise Value	$6.42B	$6.12B
Price	$14.62	$99.87
P/E Ratio	N/A	N/A
P/S Ratio	20.09x	0.00x
EV/Sales	19.75x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	8.75x	97.16x
P/FCF Ratio	N/A	N/A
EV/FCF	-21.65x	-38.30x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	12.69x	N/A
Revenue & Growth
Revenue (TTM)	$325M	$0
Revenue Growth (YoY)	34.5%	N/A
Forward Rev Growth	39.2%	455.7%
Profitability
Gross Margin (TTM)	48.4%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-79.8%	0.0%
Net Margin (TTM)	-89.1%	0.0%
FCF Margin (TTM)	-91.2%	N/A
Net Income (TTM)	$-290M	$-242M
FCF (TTM)	$-296M	$-160M
EPS (TTM)	-$0.64	-$3.86
ROE (TTM)	-4051.0%	-27323.0%
ROA (TTM)	-3165.0%	-8548.0%
ROIC (TTM)	-4047.0%	-27323.0%
Financial Health
Cash	$111M	$126M
Debt	$0	$0
Net Cash/Debt	$111M	$126M
Current Ratio (TTM)	4.35x	2.49x
Quick Ratio (TTM)	3.74x	2.39x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.76	1.95
52W Performance	544.1%	590.7%
YTD Performance	480.2%	283.8%
% from 52W High	-4.4%	-4.0%
% from 52W Low	730.7%	812.9%
Efficiency & Yields
Asset Turnover (TTM)	0.36x	0.00x
FCF Yield (TTM)	-4.5%	-2.6%
Earnings Yield (TTM)	-4.4%	-3.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-56.7	0.0
EV/GP/RG	0.68	N/A
Ticker research	View IOVA research	View KOD research

Valuation

P/S Ratio

KOD

0.00x

IOVA

20.09x

EV/FCF

KOD

-38.30x

IOVA

-21.65x

Growth & revenue

Revenue Growth TTM

IOVA

34.5%

Forward Revenue Growth

KOD

455.7%

IOVA

39.2%

Profitability & performance

Gross Margin

IOVA

48.4%

KOD

0.0%

ROE

IOVA

-4051.0%

KOD

-27323.0%

FCF Yield %

KOD

-2.6%

IOVA

-4.5%

52-Week Performance

KOD

590.7%

IOVA

544.1%

Detailed metrics comparison

IOVA

Iovance Biotherapeutics Inc

KOD

Kodiak Sciences Inc

Market Cap

IOVA$6.53B

KOD$6.25B

Enterprise Value

IOVA$6.42B

KOD$6.12B

Price

IOVA$14.62

KOD$99.87

P/E Ratio

IOVAN/A

KODN/A

P/S Ratio

IOVA20.09x

KOD0.00x

EV/Sales

IOVA19.75x

KOD0.00x

EV/EBITDA

IOVA0.00x

KOD0.00x

P/B Ratio

IOVA8.75x

KOD97.16x

P/FCF Ratio

IOVAN/A

KODN/A

EV/FCF

IOVA-21.65x

KOD-38.30x

PEG Ratio

IOVAN/A

KODN/A

Forward P/E (NTM)

IOVAN/A

KODN/A

Forward P/S (NTM)

IOVA12.69x

KODN/A

Revenue (TTM)

IOVA$325M

KOD$0

Revenue Growth (YoY)

IOVA34.5%

KODN/A

Forward Rev Growth

IOVA39.2%

KOD455.7%

Gross Margin (TTM)

IOVA48.4%

KOD0.0%

Operating Margin (TTM)

IOVA0.0%

KOD0.0%

EBITDA Margin (TTM)

IOVA-79.8%

KOD0.0%

Net Margin (TTM)

IOVA-89.1%

KOD0.0%

FCF Margin (TTM)

IOVA-91.2%

KODN/A

Net Income (TTM)

IOVA$-290M

KOD$-242M

FCF (TTM)

IOVA$-296M

KOD$-160M

EPS (TTM)

IOVA-$0.64

KOD-$3.86

ROE (TTM)

IOVA-4051.0%

KOD-27323.0%

ROA (TTM)

IOVA-3165.0%

KOD-8548.0%

ROIC (TTM)

IOVA-4047.0%

KOD-27323.0%

Cash

IOVA$111M

KOD$126M

Debt

IOVA$0

KOD$0

Net Cash/Debt

IOVA$111M

KOD$126M

Current Ratio (TTM)

IOVA4.35x

KOD2.49x

Quick Ratio (TTM)

IOVA3.74x

KOD2.39x

Debt/Equity (TTM)

IOVA0.00x

KOD0.00x

Debt/Assets (TTM)

IOVA0.0%

KOD0.0%

Interest Coverage (TTM)

IOVAN/A

KODN/A

Net Debt/EBITDA (TTM)

IOVA0.00x

KOD0.00x

Beta

IOVA0.76

KOD1.95

52W Performance

IOVA544.1%

KOD590.7%

YTD Performance

IOVA480.2%

KOD283.8%

% from 52W High

IOVA-4.4%

KOD-4.0%

% from 52W Low

IOVA730.7%

KOD812.9%

Asset Turnover (TTM)

IOVA0.36x

KOD0.00x

FCF Yield (TTM)

IOVA-4.5%

KOD-2.6%

Earnings Yield (TTM)

IOVA-4.4%

KOD-3.9%

Dividend Yield (TTM)

IOVAN/A

KODN/A

Rule of 40

IOVA-56.7

KOD0.0

EV/GP/RG

IOVA0.68

KODN/A

Ticker research

View IOVA research View KOD research

Metric	IOVA Iovance Biotherapeutics Inc	KOD Kodiak Sciences Inc
Market & Valuation
Market Cap	$6.53B	$6.25B
Enterprise Value	$6.42B	$6.12B
Price	$14.62	$99.87
P/E Ratio	N/A	N/A
P/S Ratio	20.09x	0.00x
EV/Sales	19.75x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	8.75x	97.16x
P/FCF Ratio	N/A	N/A
EV/FCF	-21.65x	-38.30x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	12.69x	N/A
Revenue & Growth
Revenue (TTM)	$325M	$0
Revenue Growth (YoY)	34.5%	N/A
Forward Rev Growth	39.2%	455.7%
Profitability
Gross Margin (TTM)	48.4%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-79.8%	0.0%
Net Margin (TTM)	-89.1%	0.0%
FCF Margin (TTM)	-91.2%	N/A
Net Income (TTM)	$-290M	$-242M
FCF (TTM)	$-296M	$-160M
EPS (TTM)	-$0.64	-$3.86
ROE (TTM)	-4051.0%	-27323.0%
ROA (TTM)	-3165.0%	-8548.0%
ROIC (TTM)	-4047.0%	-27323.0%
Financial Health
Cash	$111M	$126M
Debt	$0	$0
Net Cash/Debt	$111M	$126M
Current Ratio (TTM)	4.35x	2.49x
Quick Ratio (TTM)	3.74x	2.39x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.76	1.95
52W Performance	544.1%	590.7%
YTD Performance	480.2%	283.8%
% from 52W High	-4.4%	-4.0%
% from 52W Low	730.7%	812.9%
Efficiency & Yields
Asset Turnover (TTM)	0.36x	0.00x
FCF Yield (TTM)	-4.5%	-2.6%
Earnings Yield (TTM)	-4.4%	-3.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-56.7	0.0
EV/GP/RG	0.68	N/A
Ticker research	View IOVA research	View KOD research